Worth reading
40Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
220000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of the Eighth Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
発行・処分する株式数
New shares 220,000 shares / Treasury shares transferred 0 shares
Intended allottee
Name EVO FUND / Number of Shares Not disclosed
発行済株式総数
2.4% (exercise ratio subject to exercise restrictions)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥535, ¥538, ¥534, ¥470, ¥458 and ¥455 (exercise prices on each business day in May 2026). Details of the adjustment clause and the floor price: Not disclosed
Number of Stock Acquisition Rights
Total issued: 85,000 rights; exercised during the subject month: 2,200 rights; unexercised at the end of the month preceding the subject month: 57,400 rights; unexercised at the end of the subject month: 55,200 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Timing 12 December 2025 / Type Issuance of the Eighth Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the Eighth Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause) |
| Number of shares to be issued or disposed of | New shares 220,000 shares / Treasury shares transferred 0 shares |
| Intended allottee | Name EVO FUND / Number of Shares Not disclosed |
| Dilution Rate | 2.4% (exercise ratio subject to exercise restrictions) |
| Total number of issued shares | 12,012,901 shares (as of the end of the month preceding the subject month) → Not disclosed |
| Exercise price | ¥535, ¥538, ¥534, ¥470, ¥458 and ¥455 (exercise prices on each business day in May 2026). Details of the adjustment clause and the floor price: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 85,000 rights; exercised during the subject month: 2,200 rights; unexercised at the end of the month preceding the subject month: 57,400 rights; unexercised at the end of the subject month: 55,200 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 12 December 2025 / Type Issuance of the Eighth Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) / Amount Not disclosed |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This reports the monthly exercise status in May 2026 of the Eighth Series of Stock Acquisition Rights issued on 12 December 2025.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.